ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Eurofins Environment Testing Adds Omicron Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks

December 3, 2021 GMT

LUXEMBOURG--(BUSINESS WIRE)--Dec 3, 2021--

Eurofins Environment Testing adds Omicron variant detection capabilities to its commercially available SARS-CoV-2 test portfolio. The Omicron variant has been identified as a ‘variant of concern’ by the World Health Organization (WHO) due to the high number of mutations in the spike protein and indications of high transmissibility.

The monitoring of wastewater, environmental surface, air and worn mask testing, available as part of the Eurofins COVID-19 Sentinel™ and SAFER@WORK™ programs, provides an early warning of the presence of SARS-CoV-2 and its variants amongst large populations or at a given site. This provides crucial information for monitoring viral spread and allows for relevant containment measures to be put in place to avoid an outbreak of the disease even before symptom onset.

Eurofins Environment Testing is able to detect all known SARS-CoV-2 variants in wastewater, air, environmental surfaces and worn masks. Utilizing single point mutations in RT-qPCR, the currently dominant Delta variant can be distinguished from other variants including the new Omicron variant.

ADVERTISEMENT

For more information, visit EurofinsUS.com/Env.

About Eurofins Environment Testing America
The Eurofins Environment Testing network in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring, and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities.

About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

View source version on businesswire.com:https://www.businesswire.com/news/home/20211203005306/en/

CONTACT: Brian Williams

ir@eurofins.com

KEYWORD: LUXEMBOURG EUROPE

INDUSTRY KEYWORD: OTHER HEALTH MANAGED CARE GENERAL HEALTH PROFESSIONAL SERVICES PHARMACEUTICAL INFECTIOUS DISEASES HOSPITALS GENETICS OTHER PROFESSIONAL SERVICES BIOTECHNOLOGY MEDICAL SUPPLIES HEALTH

SOURCE: Eurofins Scientific

Copyright Business Wire 2021.

PUB: 12/03/2021 08:41 AM/DISC: 12/03/2021 08:41 AM

http://www.businesswire.com/news/home/20211203005306/en